Key Details
Price
$11.91Annual ROE
-89.13%Beta
0.21Events Calendar
Next earnings date:
Mar 18, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Mar 18, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Aug 28, 2024Analyst ratings
Recent major analysts updates
Jan 21, 25 TD Cowen
BuyDec 4, 24 Chardan Capital
BuyNov 15, 24 Chardan Capital
BuyAug 19, 24 Chardan Capital
BuyMay 30, 24 Brookline Capital
BuyApr 8, 24 Ladenburg Thalmann
BuySep 20, 21 Chardan Capital
NeutralSep 3, 21 Truist Securities
HoldSep 3, 21 Ladenburg Thalmann
NeutralSep 3, 21 Chardan Capital
SellMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Forte Biosciences doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Forte Biosciences (FBRX) Is a Great Choice for 'Trend' Investors, Here's Why
FBRX
zacks.comJanuary 3, 2025
Forte Biosciences (FBRX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Here's Why Momentum in Forte Biosciences (FBRX) Should Keep going
FBRX
zacks.comNovember 28, 2024
Forte Biosciences (FBRX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Forte Biosciences (FBRX) Upgraded to Buy: What Does It Mean for the Stock?
FBRX
zacks.comNovember 19, 2024
Forte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What Makes Forte Biosciences (FBRX) a New Buy Stock
FBRX
Zacks Investment ResearchMarch 25, 2024
Forte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
FAQ
- What is the ticker symbol for Forte Biosciences?
- Does Forte Biosciences pay dividends?
- What sector is Forte Biosciences in?
- What industry is Forte Biosciences in?
- What country is Forte Biosciences based in?
- When did Forte Biosciences go public?
- Is Forte Biosciences in the S&P 500?
- Is Forte Biosciences in the NASDAQ 100?
- Is Forte Biosciences in the Dow Jones?
- When was Forte Biosciences's last earnings report?
- When does Forte Biosciences report earnings?
- Should I buy Forte Biosciences stock now?
What is the ticker symbol for Forte Biosciences?
The ticker symbol for Forte Biosciences is NASDAQ:FBRX
Does Forte Biosciences pay dividends?
No, Forte Biosciences does not pay dividends
What sector is Forte Biosciences in?
Forte Biosciences is in the Healthcare sector
What industry is Forte Biosciences in?
Forte Biosciences is in the Biotechnology industry
What country is Forte Biosciences based in?
Forte Biosciences is headquartered in United States
When did Forte Biosciences go public?
Forte Biosciences's initial public offering (IPO) was on April 13, 2017
Is Forte Biosciences in the S&P 500?
No, Forte Biosciences is not included in the S&P 500 index
Is Forte Biosciences in the NASDAQ 100?
No, Forte Biosciences is not included in the NASDAQ 100 index
Is Forte Biosciences in the Dow Jones?
No, Forte Biosciences is not included in the Dow Jones index
When was Forte Biosciences's last earnings report?
Forte Biosciences's most recent earnings report was on Nov 14, 2024
When does Forte Biosciences report earnings?
The next expected earnings date for Forte Biosciences is Mar 18, 2025
Should I buy Forte Biosciences stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions